Farther Finance Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
1,599
-10
-0.6% -$2.07K ﹤0.01% 1914
2026
Q1
$359K Sell
1,609
-1,048
-39% -$261K ﹤0.01% 1619
2025
Q4
$640K Buy
2,657
+486
+22% +$124K 0.01% 1155
2025
Q3
$594K Buy
2,171
+1,537
+242% +$420K 0.01% 991
2025
Q2
$163K Buy
634
+6
+1% +$1.43K ﹤0.01% 1490
2025
Q1
$140K Sell
628
-31
-5% -$7.24K ﹤0.01% 1383
2024
Q4
$151K Sell
659
-9
-1% -$2.17K 0.01% 1125
2024
Q3
$163K Buy
668
+28
+4% +$6.26K 0.01% 1083
2024
Q2
$120K Sell
640
-242
-27% -$49.1K 0.01% 1055
2024
Q1
$167K Buy
882
+148
+20% +$27.1K 0.01% 750
2023
Q4
$126K Buy
734
+544
+286% +$83.6K 0.01% 716
2023
Q3
$28.1K Buy
190
+42
+28% +$7.59K ﹤0.01% 987
2023
Q2
$32.3K Buy
148
+4
+3% +$892 0.01% 827
2023
Q1
$31.5K Buy
144
+18
+14% +$3.9K 0.01% 755
2022
Q4
$26.2K Buy
+126
New +$27.7K 0.01% 647

Other funds holding RMD

Farther Finance Advisors's RMD Position: Q2 2026 in Review

Farther Finance Advisors reduced its ResMed (RMD) stake by 0.62% in Q2 2026, selling an estimated $2.07K and leaving 1,599 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

Farther Finance Advisors first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $640K in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Farther Finance Advisors held 1,599 shares of ResMed worth $312K as of Q2 2026.
  • Farther Finance Advisors sold 10 ResMed shares in Q2 2026, an estimated $2.07K.
  • ResMed made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1914 holding.
  • Farther Finance Advisors first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's ResMed position peaked at $640K in Q4 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.